H.B. Fuller Co. announced the appointment of Celine Martin to its board of directors, effective December 1, 2025. H.B. Fuller reports that Martin brings more than 30 years of experience in the global medtech industry, with deep expertise across surgical, cardiology, endovascular, and neurovascular segments. Her appointment reinforces H.B. Fuller’s strategic focus on expanding its presence in high-margin, high-growth markets like medical, and supports the company’s journey toward achieving a greater than 20% EBITDA margin.

Martin most recently served from 2022 to 2025 as the company group chairman of the Cardiovascular & Specialty Solutions (CSS) group at Johnson & Johnson. As a member of the Johnson & Johnson Medical Devices Group Operating committee, she led a diverse portfolio of medical device businesses including Electrophysiology, Neurovascular Intervention, Ear Nose and Throat, and Breast Aesthetics. Before that, Martin held several roles of increasing responsibilities including company group chairman, overseeing the surgical instrument portfolio of Ethicon, maker of Dermabond topical adhesives, from 2018 to 2021. Over her 30-year career, both in the United States and internationally, she played a vital role in advancing the ambition of Johnson & Johnson MedTech, including developing new categories and advancing standards of care for atrial fibrillation, stroke, and minimally invasive surgery.

“Celine’s appointment reflects our commitment to bold leadership and strategic focus in high-growth markets like medical,” said Celeste Mastin, president and CEO, H.B. Fuller. “Her deep expertise in the global MedTech industry and her collaborative work with the medical community align seamlessly with H.B. Fuller’s customer-centric approach to innovation. Together, we see incredible opportunity to unlock new solutions and accelerate our transformation journey toward a greater than 20% EBITDA margin. Her perspective will be instrumental as we continue to bring better patient outcomes while driving profitable growth.”

“Joining H.B. Fuller’s Board of Directors is a tremendous opportunity to contribute to an industry leader and innovator. The medical industry presents significant potential for adhesives that enhance patient care and outcomes. H.B. Fuller’s commitment to innovation, its strategic focus on high-growth markets like medical, and its focus on elevating customer experience and operational excellence align closely with my passion for improving lives through technology. I look forward to contributing to the company’s continued success and supporting its ambitious growth strategy,” said Martin.

Martin holds an MBA from Wake Forest University and a graduate degree in marketing from EM Normandie Business School.

Read more about H.B. Fuller at www.hbfuller.com.

Learn the latest news from the top adhesive and sealant manufacturers here.